Legal & General Group Plc - APREA THERAPEUTICS INC ownership

APREA THERAPEUTICS INC's ticker is APRE and the CUSIP is 03836J102. A total of 50 filers reported holding APREA THERAPEUTICS INC in Q1 2020. The put-call ratio across all filers is - and the average weighting 0.9%.

Quarter-by-quarter ownership
Legal & General Group Plc ownership history of APREA THERAPEUTICS INC
ValueSharesWeighting
Q1 2021$6,0000.0%1,2730.0%0.00%
Q4 2020$6,000
-81.2%
1,273
-2.6%
0.00%
Q3 2020$32,000
-49.2%
1,307
-18.9%
0.00%
Q2 2020$63,000
+75.0%
1,612
+54.1%
0.00%
Q1 2020$36,000
-39.0%
1,046
-18.3%
0.00%
Q4 2019$59,0001,2810.00%
Other shareholders
APREA THERAPEUTICS INC shareholders Q1 2020
NameSharesValueWeighting ↓
5AM Venture Management, LLC 2,212,654$85,807,00018.79%
Versant Venture Management, LLC 1,854,229$71,907,001,00010.33%
SECTORAL ASSET MANAGEMENT INC 915,681$35,510,0003.26%
Consonance Capital Management LP 1,252,185$48,560,0002.91%
Redmile Group, LLC 2,268,718$87,981,0001.62%
SPHERA FUNDS MANAGEMENT LTD. 158,289$6,138,0000.58%
Rock Springs Capital Management LP 518,290$20,099,0000.55%
Parkman Healthcare Partners LLC 40,036$1,553,0000.44%
Virtus ETF Advisers LLC 11,435$443,0000.21%
KENNEDY CAPITAL MANAGEMENT LLC 131,414$5,096,0000.15%
View complete list of APREA THERAPEUTICS INC shareholders